直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
    • AI + Finnegan
    • Appeals, Issues, and Legal Strategy
    • Diligence, Licensing, and Opinions
    • Global IP Enforcement, Litigation, and Trials
    • Patent Office Invalidation Proceedings
    • Prosecution and Portfolio Management
    • Trademark and Brand Management
    • AI, Electronics, and Information Technology
    • Chemicals, Industrials, and Materials
    • Communications
    • Consumer Goods and Services
    • Energy
    • Hospitality, Gaming, and Leisure
    • Life Sciences
    • Transportation and Logistics
  • Experience

Experience

Securing $240 million and a jury verdict of willful infringement for Promptu in patent case against Comcast

Promptu Systems Corporation

US Synthetic secures ITC exclusion order barring polycrystalline diamond compacts (PDCs)

US Synthetic Corporation

Achieving precedent in preserving valuable patents for Lumify®

Eye Therapies, LLC

Finnegan client Maglula delivers crushing blow to Amazon’s arbitration practices over counterfeit products

Maglula, Ltd.

Finnegan secures $180M for CSRC in complex arbitrations

CSRC et al.

Protecting a blockbuster diabetes treatment for AstraZeneca

AstraZeneca AB

Major victories across IP venues for Volkswagen, Audi, Bentley, and Lamborghini

Audi AG; Audi of America, LLC; Automobili Lamborghini America, LLC; Automobili Lamborghini S.p.A.; Bentley Motors Limited; Bentley Motors, Inc; Volkswagen AG; Volkswagen Group of America, Inc.

Finnegan tees up valuable patents for Eisai, leading to major strategic collaboration agreement

Eisai Co., Ltd.

Finnegan helps Intellia Therapeutics acquire Rewrite Therapeutics, Inc. for $45 million

Intellia Therapeutics, Inc.

Recent Experience

Experience

Incyte Corporation et al. v. Sun Pharmaceutical Industries Limited et al. Incyte Corporation et al. v. Sun Pharmaceutical Industries Limited et al.

2:24-cv-06944, D.N.J., Judge Padin

Experience

Merck Sharp & Dohme LLC v. Hetero USA Inc., Lupin Limited et al. Merck Sharp & Dohme LLC v. Hetero USA Inc., Lupin Limited et al.

2:23-cv-00094, 2:23-cv-02364, D.N.J., Judges Cecchi, Padin, Wettre

Experience

Duchesnay Inc. v. Actavis Laboratories FL, Inc. et al. Duchesnay Inc. v. Actavis Laboratories FL, Inc. et al.

1:18-cv-01895, D. Del., Judges Andrews, Fallon

Experience

In re Fetzima In re Fetzima

2:17-cv-10230, D.N.J., Judges Mannion, Salas

Experience

Teva Pharmaceuticals International GmbH v. Eli Lilly and Company Teva Pharmaceuticals International GmbH v. Eli Lilly and Company

1:18-cv-12029, D. Mass., Judge Burroughs

Experience

Alzheimer's Institute of America, Inc. v. Avid Radiopharmaceuticals Alzheimer's Institute of America, Inc. v. Avid Radiopharmaceuticals

2:10-cv-06908, E.D. Pa., Judges Angell, Savage, Cohen (Special Master)
13-1544, 16-2647, Fed. Cir., Judges Hughes, Lourie, Moore, Newman, Plager

Experience

Eli Lilly and Company v. Actavis Labs. UT Inc. Eli Lilly and Company v. Actavis Labs. UT Inc.

1:16-cv-01119, E.D. Va., Judges Nachmanoff, Trenga

Experience

Federal Circuit, district court, and arbitration victories protect Cumberland Pharmaceuticals’ flagship product, Acetadote® Federal Circuit, district court, and arbitration victories protect Cumberland Pharmaceuticals’ flagship product, Acetadote®

16-1155, -1259, Fed. Cir., Judges Moore, Reyna, Taranto
1:12-cv-03846, N.D. Ill., Judge Pallmeyer

Experience

Duchesnay, Inc. v. Actavis Laboratories Inc. and Mylan Pharmaceuticals, Inc. Duchesnay, Inc. v. Actavis Laboratories Inc. and Mylan Pharmaceuticals, Inc.

1:14-cv-00912, D. Del., Judges Robinson, Fallon

Experience

District court finds patent covering Cephalon’s wakefulness improving drug Nuvigil®, valid in ANDA litigation District court finds patent covering Cephalon’s wakefulness improving drug Nuvigil®, valid in ANDA litigation

1:10-md-02200, D. Del., Judge Sleet

Experience

U.S. Court finds patent covering AstraZeneca’s anti-cholesterol drug Crestor®, is valid and enforceable in ANDA litigation U.S. Court finds patent covering AstraZeneca’s anti-cholesterol drug Crestor®, is valid and enforceable in ANDA litigation

1:08-md-01949, D. Del., Judges Farnan, Stark
10-1460, -1461, -1462, -1463, -1464, -1465, -1466, -1467, -1468, -1469, -1470, -1471, -1472, -1473, Fed. Cir., Judges Mayer, Newman, Plager

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP